Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ligand Pharmaceuticals Inc (LGND)  
$198.41 3.82 (1.96%) as of 4:30 Thu 12/18


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 19,290,000
Market Cap: 3.83(B)
Last Volume: 562,071 Avg Vol: 557,902
52 Week Range: $96.67 - $209.29
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  196
Guru Rank Value     : 7.3
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Ligand Pharmaceuticals is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Co. employs research technologies such as antibody discovery technologies, ion channel discovery technology, Pseudomonas fluorescens protein expression technology, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals. Co.'s collaboration partners and licensees have programs in clinical development targeting cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 11,010 13,510
Total Buy Value $0 $0 $1,156,546 $1,400,027
Total People Bought 0 0 2 2
Total Buy Transactions 0 0 2 3
Total Shares Sold 23,955 26,323 34,927 139,116
Total Sell Value $4,520,863 $4,832,016 $5,813,286 $15,731,650
Total People Sold 5 6 6 8
Total Sell Transactions 7 11 15 34
End Date 2025-09-19 2025-06-18 2024-12-18 2023-12-19

   
Records found: 540
  Page 1 of 22  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Espinoza Octavio Chief Financial Officer   •       –      –    2025-12-16 4 OE $52.84 $164,298 D/D 2,381 28,567     -
   Espinoza Octavio Chief Financial Officer   •       –      –    2025-12-12 4 S $188.31 $339,711 D/D (1,804) 26,186 -3%     
   Aryeh Jason Director   –       •      –    2025-12-08 4 OE $69.51 $141,383 D/D 2,034 71,323     -
   Espinoza Octavio Chief Financial Officer   •       –      –    2025-12-05 4 D $184.87 $344,228 D/D (1,862) 27,990     -
   Davis Todd C Chief Executive Officer   •       •      –    2025-12-04 4 GD $0.00 $0 D/D 130 161,337     -
   Kozarich John W Director   –       •      –    2025-12-01 4 AS $193.86 $91,457 D/D (467) 44,121 -4%     
   Gray Nancy Ryan Director   –       •      –    2025-11-07 4 S $205.45 $1,350,012 D/D (6,571) 8,094 4%     
   Gray Nancy Ryan Director   –       •      –    2025-11-07 4 OE $66.19 $457,185 D/D 6,571 11,109     -
   Lamattina John L Director   –       •      –    2025-11-07 4 S $205.45 $858,576 D/D (4,179) 30,724 4%     
   Lamattina John L Director   –       •      –    2025-11-07 4 OE $66.13 $283,232 D/D 4,179 32,758     -
   Kozarich John W Director   –       •      –    2025-11-03 4 AS $189.00 $89,219 D/D (467) 44,588 -1%     
   Kozarich John W Director   –       •      –    2025-10-01 4 AS $177.60 $83,800 D/D (467) 45,055 6%     
   Aryeh Jason Director   –       •      –    2025-09-23 4 S $170.41 $1,708,088 D/D (10,000) 69,289 -14%     
   Zimmermann Martine Director   –       •      –    2025-09-22 4 D $170.77 $19,639 D/D (115) 4,443     -
   Kozarich John W Director   –       •      –    2025-09-02 4 AS $161.51 $75,775 D/D (467) 45,522 16%     
   Reardon Andrew CLO & Secretary   •       –      –    2025-08-10 4 D $150.06 $198,830 D/D (1,325) 30,811     -
   Kozarich John W Director   –       •      –    2025-08-01 4 AS $131.88 $61,586 D/D (467) 45,989 40%     
   Kozarich John W Director   –       •      –    2025-07-10 4 AS $125.00 $116,750 D/D (934) 46,456 61%     
   Espinoza Octavio Chief Financial Officer   •       –      –    2025-06-30 4 A $91.08 $20,401 D/D 224 29,852     -
   Reardon Andrew CLO & Secretary   •       –      –    2025-06-30 4 A $91.08 $21,221 D/D 233 32,136     -
   Davis Todd C Chief Executive Officer   •       •      –    2025-06-30 4 A $91.08 $21,221 D/D 233 161,467     -
   Reardon Andrew CLO & Secretary   •       –      –    2025-06-23 4 S $114.08 $57,042 D/D (500) 31,903 -60%     
   Reardon Andrew CLO & Secretary   •       –      –    2025-06-10 4 S $114.54 $57,271 D/D (500) 32,403 -60%     
   Haas Jason Director   –       •      –    2025-06-06 4 A $0.00 $0 D/D 1,209 6,606     -
   Aryeh Jason Director   –       •      –    2025-06-06 4 A $0.00 $0 D/D 1,209 79,289     -
  540 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 22
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us